Paracetamol tablets recalled over fungal contamination fears


Facebook
Twitter
LinkedIn

By Costanza Pearce
Reporter

13 Jun 2019

Certain batches of paracetamol 500mg tablets made by the manufacturer M & A Pharmachem are being recalled due to fungal contamination.

Discoloured tablets have been detected in a small number of pots from two batches that have been contaminated with Penicillium citrinium and Penicillium brevicompactum, said the Medicines and Healthcare products Regulation Agency (MHRA) today (13 June).

It is ‘unlikely’ that any affected tablets will have reached patients as the discolouration is ‘noticeable’ when the pack is opened, the medicines watchdog stressed.

However, pharmacists should stop dispensing the affected batches immediately, quarantine them and return all the remaining stock to the supplier within 48 hours, the MHRA said.

The affected batches can be viewed here.


Want news like this straight to your inbox?


Latest News

Primary prevention statins benefit ‘may be marginal’ for healthy patients, says study
The benefits of statins for primary prevention in healthy patients is unclear and a ’waste...
25% pharmacists say medicines shortages have led to patient harm, says PDA survey
One in four pharmacists have seen medicines shortages lead to patient harm in the past...
Sponsored: help your patients manage joint pain effectively
This article has been produced and funded by GSK.  Joint pain is an extremely common...